Study examines the extent of medication-related harm in pediatric intensive care units

NewsGuard 100/100 Score

In an observational study conducted across three pediatric intensive care units (PICUs) in England over a three-month period in 2019, one-sixth of patients experienced at least one adverse drug event, in which they were harmed by a medication.

In the study published in the British Journal of Clinical Pharmacology, 302 patients were included and 62 adverse drug events were confirmed. The estimated incidence of adverse drug events were 20.5 per 100 patients, and most were preventable. Medications for the central nervous system, infections, and the cardiovascular system were commonly implicated with adverse drug events.

This multicentre study is the first of its kind in the UK hospitals, and its findings can guide future remedial interventions to reduce avoidable medication-related harm in this vulnerable patient population."

Anwar A. Alghamdi, PhD, Lead author, University of Manchester, UK

Source:
Journal reference:

Alghamdi, A.A., et al. (2021) Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study. British Journal of Clinical Pharmacology. doi.org/10.1111/bcp.15150.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Anesthetic midazolam boosts survival after cardiac arrest